MDM2 is a ubiquitin ligase that plays a key role in regulating the stability of the p53 tumor suppressor protein. Several proteins have been shown to activate the p53 pathway by interacting with and inhibiting the E3 function of MDM2, thereby leading to an accumulation of p53. These include the alternate reading frame (ARF) proteins and the ribosomal proteins L5 and L11. We found that when overexpressed alone, L11 is much less potent in inhibiting MDM2 than p14 ARF . However, L11 cooperates with L5, resulting in a robust inhibition of the E3 activity of MDM2, and a stabilization and activation of p53 approaching that achieved by p14 ARF . We further showed that the ability of L11 to bind the 5S rRNA is important for the cooperation with L5, and a mutant L11, which cannot bind the 5S rRNA, cannot cooperate with L5 in inhibiting MDM2.
Introduction
The transcription factor p53 is a tumor suppressor that responds to a myriad of cellular stresses to promote cellcycle arrest or apoptosis (Vogelstein et al., 2000) . p53 function and stability are highly regulated, and the RING finger protein MDM2 is one of the major regulators of p53 (Toledo and Wahl, 2006) . Although the interaction of MDM2 with p53 can inhibit the transcriptional activity of p53 directly (Momand et al., 1992; Thut et al., 1997) , the critical function of MDM2 is as a ubiquitin ligase, regulating p53 stability by promoting its ubiquitination and subsequent degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Itahana et al., 2007) . In normal, non-stressed cells, MDM2 keeps p53 activity low. Upon cellular stress, MDM2 activity towards p53 is inhibited through a number of mechanisms, including phosphorylation, acetylation and the binding of inhibitory proteins (Brooks and Gu, 2003; Toledo and Wahl, 2006) .
One well-established stress that promotes the stabilization and activation of p53 is the expression of active oncogenes (Christophorou et al., 2006; Efeyan et al., 2006; Efeyan and Serrano, 2007) . Oncogene activation leads to increased expression of the alternate reading frame (ARF) protein (p14 ARF in humans, p19 ARF in mice) (Efeyan and Serrano, 2007) that binds MDM2 in its central region and inhibits its E3 ligase activity (Kamijo et al., 1998; Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998; Honda and Yasuda, 1999; Bothner et al., 2001) , promoting p53 stabilization and activation.
Recently, several studies have shown that ribosomal stress also activates p53. For example, mice lacking the transcription initiation factor 1A (TIF1A), a critical cofactor for RNA polI that transcribes most of the rRNA, exhibit elevated p53 levels-an activity that is brought about by the increased binding of ribosomal proteins, such as L11, to MDM2 (Yuan et al., 2005) . In fact, several ribosomal proteins have been shown to function in similar manner to ARF, by inhibiting the E3 ligase activity of MDM2. These proteins including ribosomal proteins L5, L11 and L23 (Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004; Jin et al., 2004) . Treatment of cells with low levels of actinomycin D (ActD) inhibits RNA polI (Perry and Kelley, 1970) and promotes the association between MDM2 and these ribosomal proteins, leading to a p53-dependent cell-cycle arrest. Ribosomal stress induced through the mutation of Bop-1, a protein involved in the processing of ribosomal RNA, also results in a p53-dependent cell-cycle arrest (Pestov et al., 2001) . The ribosomal proteins may also play a role in cell-cell contact inhibition and serum starvation, both of which have been shown to promote the interaction between L11 and MDM2 in cultured cells (Bhat et al., 2004) .
L5, L11 and L23 all bind to the central acidic domain and adjacent zinc finger region of MDM2 (Lohrum et al., 2003; Zhang et al., 2003; Jin et al., 2004; Lindstrom et al., 2007) . This same area has been shown to be important for ARF binding (Bothner et al., 2001) and raises the possibility that the ribosomal proteins and ARF may function in a similar manner to inhibit MDM2 E3 ligase activity.
Our present studies suggest that p14 ARF is much more potent than L11 in promoting p53 stabilization and activation. Previous studies have shown that depletion of either L11 or L5 significantly impedes the stabilization of p53 in response to ribosomal stress (Bhat et al., 2004; Sun et al., 2008) . We show here that L11 cooperates with L5 to inhibit MDM2 and that when these two ribosomal proteins are combined, their activity approaches that of p14 ARF . Furthermore, this ability of L11 and L5 to cooperate depends on their ability to interact with each other, apparently through the 5S rRNA.
Results

L11 is less potent than p14
ARF in stabilizing p53 L11 and p14
ARF have both been shown to bind the central region of MDM2, which spans the acidic domain and the zinc finger (Bothner et al., 2001; Lindstrom et al., 2007) , and both have been shown to inhibit the degradation of p53 by inhibiting the MDM2 E3 ligase activity (Kamijo et al., 1998; Pomerantz et al., 1998; Stott et al., 1998; Honda and Yasuda, 1999; Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004; Dai et al., 2006) . We performed a direct comparison between the ability of flag-tagged p14 ARF and flag-tagged L11 to stabilize p53 and inhibit MDM2 E3 ligase activity. In doing so, we found that p14 ARF was significantly more potent than L11 in inhibiting MDM2-mediated p53 degradation (Figure 1 ). When increasing levels of p14 ARF and L11 were co-transfected with MDM2 and p53, p14
ARF caused a robust inhibition of MDM2-mediated p53 degradation, even at low levels of expression ( Figure 1a ). However, even at the highest expression level, L11 exhibited only weak p53 stabilization in comparison to that seen by p14 ARF . Much higher amounts of L11 than p14 ARF were necessary to obtain comparable levels of p53 stabilization (Figure 1b) , and even at these elevated L11 levels, the p53 stabilization is not as robust as that seen with p14 ARF . Furthermore, L11 appears to promote rather weak activation of p53 function, as evidenced by poor induction of p21 WAF1/CIP1 , the product of a p53 transcriptional target (Figure 1b) . This is in contrast with the much stronger upregulation of p21 WAF1/CIP1 levels induced by p14 ARF expression (Figure 1b) . The increased expression of transfected MDM2 seen following co-transfection of L11 or p14 ARF in Figure 1b is likely to reflect the stabilization of the MDM2 protein, as previously described (Stott et al., 1998; Midgley et al., 2000; Dai et al., 2006) . L11 and p14 ARF stabilize p53 in response to different stimuli (Lowe, 1999; Sherr and Weber, 2000; Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004) , each of which promotes a clear p53 response. Therefore, we speculated that other proteins might be required to cooperate with L11 to robustly promote p53 stability in response to ribosomal stress. In particular, the finding that small interfering RNA (siRNA) to either L11 or L5 had the same effect of abrogating the ActD-induced p53 response (Bhat et al., 2004; suggested that L11 and L5 may act together. The crystal structure Figure 1 p14 ARF is more potent in stabilizing and activating p53 than L11. (a) At equal expression levels, p14 ARF promotes greater p53 stability than L11. U2OS cells were transfected with a flag-tagged p53 (0.2 mg), MDM2 (1 mg) and increasing amounts of flag-tagged L11 or flag-tagged p14 ARF (0.5, 1 and 2 mg) plasmid. Cell lysates were generated 36 h after transfection, and immunoblots of lysates were probed with anti-flag antibody (M2) or anti-MDM2 antibody (Ab1). (b) High levels of L11 are necessary to promote p53 stabilization. U2OS cells were transfected with a flag-tagged p53 (0.2 mg), MDM2 (1 mg), a flag-tagged L11 (1, 2.5 and 5 mg) and a flag-tagged p14 ARF (0.05, 0.1 and 0.25 mg) plasmid as indicated. Cell lysates were harvested and analysed as in (a). The blot was re-probed for the p53 target p21
WAF1/CIP1 and for actin.
of the large ribosomal subunit reveals that L5 and L11 occupy the central protrusion of the large ribosomal subunit, and both bind to the 5S rRNA (Spahn et al., 2001) . Furthermore, L11 and L5 have been shown to assemble into a complex with the 5S rRNA prior to assembly into the ribosome in both Escherichia coli and yeast (Gray et al., 1972; Spierer and Zimmermann, 1978; Zhang et al., 2007) . These observations suggest that L5 and L11 may act as a complex, perhaps also with the 5S rRNA, as all three components have been shown to bind MDM2 in independent studies (Marechal et al., 1994; Elenbaas et al., 1996; Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004; . To test if L5 and L11 function together, we included both in a p53 degradation assay (Figure 2) . Titration of increasing amounts of L11 or L5 into cells showed that both promote about equal levels of p53 stabilization. But when L11 and L5 were titrated together, they L5 and L11 cooperate to activate p53 HF Horn and KH Vousden showed a more robust ability to stabilize p53. The protein expressed from 0.25 mg of L11 and L5 DNA combined promoted a greater stabilization of p53 than the protein produced by 0.5 mg of DNA of either L11 or L5 alone (Figure 2a ), suggesting that L11 and L5 act cooperatively and not just in an additive fashion. Furthermore, combining L11 and L5 in this assay allows the levels of p53 stabilization to approach those achieved by p14 ARF (Figure 2b ). When we looked at p53 activity in this assay by blotting for p21
, we saw that the levels of p21 WAF1/CIP1 induction observed by L11 were again very low, and although L5 promoted a slightly better upregulation of p21 WAF1/CIP1 than L11 alone, the combination of L5 and L11 promoted good p21 WAF1/CIP1 induction ( Figure 2a ). Taken together, these results suggest that both L5 and L11 are necessary to effectively activate p53.
L11 and L5 cooperate to inhibit p53 ubiquitination and neddylation As we were able to show a combined effect of L5 and L11 on p53 stability, we next examined whether this increased stability was a reflection of decreased p53 ubiquitination.
U2OS cells were transfected with haemagglutinin (HA)-tagged ubiquitin, flag-p53 and MDM2. p53 is efficiently ubiquitinated by MDM2 under these conditions ( Figure 3a) . A catalytically dead MDM2 mutant (C464A) (Honda and Yasuda, 2000) did not promote ubiquitination, and the ubiquitination was also efficiently inhibited by p14 ARF , as previously reported (Sherr, 1998; Honda and Yasuda, 1999; Zhang and Xiong, 2001) . By contrast, L11 and L5 on their own are much less efficient in inhibiting the ubiquitination of p53, in agreement with their less potent ability to stabilize p53 on their own (Figure 2 ). However, combining L11 and L5 in this assay promotes more potent inhibition of ubiquitination. Thus L11 and L5 together inhibit the MDM2-mediated p53 ubiquitination to a greater extent than either does on their own.
Because the combination of L11 and L5 also promoted greater upregulation of p21 WAF1/CIP1 than L11 or L5 on their own (Figure 2) , we checked the effect of L11 and L5 on p53 neddylation, which has been shown to inhibit p53 transcriptional activity under some circumstances (Xirodimas et al., 2004) . We show that p14 ARF prevents p53 neddylation (Figure 3b ), much like it inhibits ubiquitination. When expressed alone, L11 and L5 have no profound effect on MDM2 neddylation. However, in combination, L5 and L11 show a clear ability to prevent p53 neddylation. This is consistent with the increase in p21 WAF1/CIP1 levels seen in the stabilization assay (Figure 2 ), suggesting that p53 transcriptional activity may be modulated by neddylation.
L11 promotes interaction between L5 and MDM2
As we were able to show that L11 and L5 cooperate in their inhibition of MDM2 E3 ligase activity, we wanted to understand more about the binding of these two proteins on MDM2. Because the effect of L5 and L11 on MDM2 activity is cooperative, it is reasonable to predict that L11 and L5 interact with each other on some level while binding Mdm2. To address this prediction, we began by reducing L11 levels and tested whether this affected the interaction between L5 and MDM2 (Figure 4a ). U2OS cells were transfected with a scrambled siRNA control or two different concentrations of L11 siRNA. MDM2 and a flag-tagged L5 were also transfected as indicated. A co-immunoprecipitation with flag-L5 revealed that in the presence of the scrambled L11 siRNA control, MDM2 and L5 associate robustly. However, a reduction in the levels of endogenous L11 significantly reduced the L5-MDM2 interaction (Figure 4a ). The band intensities were digitally quantified and graphed (Figure 4b ). From this graph, it is apparent that while the knockdown of L11 promotes a slight decrease in MDM2 levels, this decrease is not sufficient to be solely causal for the decrease seen in the L5-MDM2 interaction. L11 therefore appears to promote the interaction between L5 and MDM2.
If L11 promotes the interaction between L5 and MDM2, then L11 should also be important for L5 to inhibit MDM2. To address the role of L11 for L5-mediated MDM2 inhibition, we co-transfected p53, MDM2 and flag-L5 as indicated ( Figure 4c ). As shown before (Figure 2 ), p53 degradation was inhibited by L5. Transfection of a scrambled siRNA had no effect on the ability of L5 to stabilize p53. However, when the levels of L11 were reduced by siRNA, the ability of L5 to stabilize p53 was significantly impaired. This result suggests that ectopically expressed L5 cooperates with endogenous L11 to inhibit MDM2 function. Finally, to test the physiological relevance of these observations, we examined the effect of knockdown of endogenous L11 on the interaction of endogenous MDM2 with endogenous L5 (Figures 4d-f ). Ribosomal stress induced by treatment of the cells with low levels of ActD enhanced the interactions between MDM2, L11 and L5. As seen with transfected proteins, knockdown of L11 expression significantly reduced the interaction of MDM2 and L5, both in stressed and in unstressed cells. Taken together, these data therefore demonstrate that reduction of endogenous L11 not only caused a decreased binding between L5 and MDM2, but as predicted, it also significantly impaired the ability of L5 to inhibit MDM2 and promote p53 stabilization.
A 5S rRNA-binding mutant of L11 fails to cooperate with L5 On the basis of several crystal structures of the large ribosomal subunit from both bacteria and yeast and a crystal structure of the 5S rRNA with its decorating proteins (Harms et al., 2001; Spahn et al., 2001; Szymanski et al., 2003) , it is apparent that L11 and L5 do not bind each other directly when assembled into the ribosome. L11 and L5 interact through the 5S rRNA. As the 5S rRNA has been shown to bind to MDM2 (Marechal et al., 1994; Elenbaas et al., 1996) , it is possible that the 5S rRNA forms an important bridge between L5 and L11 when these proteins are bound to MDM2. If the 5S rRNA is important for the interaction between L11 and L5, then L11 and L5 should no longer al., 2002) . We used these studies to generate an L11 mutant (L11 R75Q) with impaired binding to the 5S rRNA, as indicated by the inability to efficiently coimmunoprecipitate 5S rRNA ( Figure 5 ). If the 5S rRNA forms an important link between L11 and L5, this mutant should no longer form a complex with L5 on MDM2, although it should still be able to bind MDM2 on its own. Both of these criteria were met for the R75Q mutant of L11 (Figure 6a ). The wild-type L11 interacted robustly with MDM2 and endogenous L5. The R75Q mutant L11 was able to co-immunoprecipitate MDM2, but it no longer formed a complex with L5 (Figure 6a ). This finding suggests that L11 is necessary not only for the function of L5 on MDM2, but that L11 is necessary for L5 to bind MDM2, as already indicated in Figure 4a , and that the 5S rRNA forms an important component of the interaction between L11 and L5 on MDM2.
When we tested the R75Q mutant for its ability to inhibit MDM2 and promote p53 stabilization, we found that it was not significantly impaired in its ability to stabilize p53 on its own, when compared to a wild-type L11 (Figure 6b ). However, as expected, R75Q failed to cooperate with L5. L11 R75Q did not show any significant increased stabilization of p53 when cotransfected with L5, as compared to the stabilization caused by R75Q on its own. This is in contrast with the cooperation seen between wild-type L11 and L5, where the stabilization seen with L5 and L11 is significantly greater than that with L11 on its own (Figure 6b ). These results indicate that the cooperation between L11 and L5 to promote p53 stabilization requires a physical interaction between L11 and L5, which is mediated through the 5S rRNA. The lack of an additive effect of L5 with L11 R75Q also suggests that the 5S rRNA interaction is required for the simultaneous binding of L5 and L11 (Figure 7) . Discussion L5 and L11 have been shown to bind MDM2 and inhibit its E3 ligase activity, leading to p53 stabilization (Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004; . Both proteins show increased association with MDM2 in response to ribosomal stress, such as inhibition of RNA polI by ActD (Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004; . Here we have shown that L5 and L11 cooperate in binding to MDM2 and in inhibiting MDM2 E3-ligase activity. L11 and L5 on their own are able to inhibit MDM2 function to some degree, but when compared to the inhibitory activity of p14 ARF , neither L11 nor L5 is as potent. Only when L11 and L5 are expressed together do they attain comparable levels of inhibition to those of p14 ARF . Furthermore, we were able to show that L11 contributes to the interaction between L5 and MDM2. A mutant of L11 that was unable to cooperate with L5 showed diminished 5S rRNA and L5 binding. This suggests that a physical interaction between L5 and L11, via the 5S rRNA, is necessary for robust inhibition of MDM2 E3 ligase activity and resultant p53 stabilization (Figure 7) .
It has been shown that approximately half of the 5S rRNA within a cell is in complexes outside the ribosome (Knight and Darnell, 1967; Steitz et al., 1988) , a significant portion of which exists in a complex with L5 (Steitz et al., 1988) . As L5 and the 5S rRNA have both been shown to bind MDM2, why does this nonribosomal 5S RNP not inhibit MDM2 function and promote p53 stabilization? It is possible that posttranslational modifications of the protein or RNA are necessary before they bind MDM2 efficiently, or that subcellular compartmentalization of the 5S RNP also plays a role. Alternatively, it is possible that other factors are necessary to promote the binding of the 5S RNP to MDM2, such as the presence of free L11. The idea that L11 may act as a sensor of ribosomal stress and bring L5 to MDM2 and promote robust inhibition of MDM2 E3 ligase activity is supported by our findings that L11 is necessary for L5 to bind MDM2 efficiently, and in the presence of reduced L11 levels, overexpressed L5 is poor in stabilizing p53 (Figure 4) . While other factors certainly also play a role, it seems that L11 is a limiting factor for activation of p53 by ribosomal stress through the L5/L11/5S rRNA complex.
In a recent publication, Lindstrom et al. (2007) identified several tumor-derived MDM2 mutations that fail to bind L11 and L5. A point mutation in cysteine 305 of the zinc finger motif was shown to completely destroy binding to both L11 and L5 . The exact binding site for L5 on MDM2 has not been clearly defined, with two reports locating the L5-binding region on MDM2 as spanning amino acids 153-294 and 216-284 . The 153-294 binding region overlaps slightly with the L11-binding site (aa 284-374) , but neither overlaps with the MDM2 zinc finger (aa 305-322). However, in contrast to the two previously published reports, the study that identified the tumorderived MDM2 mutants has depicted the L5-binding site as spanning a much larger region that overlaps completely with the L11-binding site. The finding that a point mutant in the L11-binding region of MDM2 loses the interaction not only with L11 but also with L5 indicates one of two things. One is that L5 and L11 bind to the same region of MDM2 and that the C305 residue is essential for binding of both proteins. However, L5 and L11 have not been shown to compete for binding to MDM2, as one would expect if they bound to the same region, and in fact, several studies have shown that L5 and L11 can form a complex with MDM2 Lindstrom et al., 2007) . The other possibility is that L5 and L11 bind cooperatively and that by abolishing binding of one protein (L11), the binding of the other protein (L5) is diminished or lost. This scenario is supported by this study, where we show that Figure 7 Model of cooperation between L5 and L11 binding to MDM2. Both L5 and L11 can bind independently to MDM2 and inhibit the degradation of p53. However, efficient inhibition of p53 degradation depends on the cooperative binding of L5 and L11, which requires an interaction with 5S rRNA.
L5 and L11 cooperate to activate p53 HF Horn and KH Vousden L11 is necessary for the interaction between L5 and MDM2.
The idea that L11, L5 and the 5S rRNA may act as a cooperative unit is supported by several reports. When FMR1, an RNA-binding protein that acts as a negative regulator of translation, was used in a pull-down assay to identify FMR1-interacting proteins, L5, L11 and the 5S rRNA were the only ribosomal components identified (Ishizuka et al., 2002) . Binding of FMR1 to L5, L11 and 5S rRNA is thought to allow the FMR1 protein to associate with the ribosome (Ishizuka et al., 2002) . Furthermore, L5 and L11, together with the 5S rRNA form the central protrusion of the large ribosomal subunit (Harms et al., 2001; Spahn et al., 2001) . The 5S rRNA and L5 can be released from the ribosome as a complex by chemical treatment of ribosomes (Blobel, 1971; Marion and Reboud, 1981) , and the 5S rRNA and L5 form a pre-ribosomal complex that assembles into the ribosome together (Steitz et al., 1988) . Thus it is possible that cells maintain a large pool of extraribosomal L5 and 5S rRNA for responding to a variety of stresses and that a ribosomal stress results in the release of L11, which then promote the binding of the 5S RNP complex to MDM2, resulting in p53 stabilization. L11 is clearly necessary, but probably not sufficient for the 5S RNP to promote p53 stabilization, as overexpression of L11 on its own does not seem to cooperate with the endogenous 5S RNP.
It will be interesting to determine the role of L23 in the context of these findings, as its behaviour is clearly distinct from that of L5 and L11 (Lohrum et al., 2003; Bhat et al., 2004; Jin et al., 2004) . However, it also appears to be essential for p53 stabilization in response to ActD, as a knockdown of L23 prevents robust activation of p53 in ActD-treated cells . But L23 differs from L5 and L11 in that knockdown of L23 on its own stabilizes and activates p53 . The knockdown of neither L5 nor L11 has this effect (Bhat et al., 2004; .
Most of the ribosomal RNA is made by RNA polI, with the exception of 5S rRNA, which is transcribed by RNA polIII (White, 2004) . Does the cell use the 5S rRNA and its associated proteins as a ribosomal stress sensor because its production is independent of the remaining ribosomal components? The effect of the 5S rRNA on the p53 pathway has not been formally shown, though the 5S rRNA has been shown to bind MDM2 (Marechal et al., 1994; Elenbaas et al., 1996) . As most of the ribosomal stress identified to date involves the defective production of the RNA polI-transcribed rRNA, it is possible that the non-polI-generated rRNA along with its associating proteins is used to signal this stress. Because p53 has been shown to inhibit 5S rRNA production (Chesnokov et al., 1996; Cairns and White, 1998; Crighton et al., 2003) , this would create another negative feedback loop involving p53. Our data hint at the possibility that 5S rRNA plays an important role in p53 stabilization, and it would be interesting to elucidate the relationship between the 5S rRNA and p53 activity further.
Materials and methods
Cell cultures
Human U2OS cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine and antibiotics at 37 1C in 5% CO 2 .
Plasmids
Plasmids coding for human flag-tagged p53, MDM2 and MDM2 mutant C464A, flag-tagged p14 ARF , flag-tagged L11, HA-tagged ubiquitin and Nedd8 have all been previously described (Marston et al., 1994; Chen et al., 1995; Stott et al., 1998; Lohrum et al., 2003; Carter et al., 2007) . Flag-tagged L5 was PCR-generated from p3L5 using primers L5FlagFor(5 0 -GCGGGATCCACCATGGATTACAAGGATGACGACGA TAAGGGGTTTGTTAAAGTTGTTAAG) and L5EcoR1Rev(5 0 -GCCGAATTCTTAGCTCTCAGCAGCCCGCTC) and cloned into pcDNA3.1 using BamH1 and EcoR1. Myc-tagged L11 was generated using primers MycL11For(5 0 -GCGCCGAA GCTTGCCACCATGGAGCAGAAACTCATCTCTGAAGA GGATCTGGCGCAGGATCAAGGTGAAAAGGAG) and L11Rev(5 0 -CGCGAATTCTTATTTGCCAGGAAGGAT) and cloned into pcDNA3.1 using EcoR1 and HindIII. The R75Q L11 was generated using site-directed mutagenesis (Stratagene, La Jolla, CA, USA) from the Myc-and flag-L11 constructs. All generated plasmids were verified by sequencing.
p53 degradation assays U2OS cells were transfected with 0.2 mg p53, 1 mg MDM2 and indicated amounts of L11, L5 and p14 ARF using calcium phosphate co-precipitation, lysed 48 h after transfection, and proteins resolved by 12% SDS-polyacrylamide gel electrophoresis. Immunoblots were probed with anti-flag (M2; Sigma, Gillingham, UK), anti-MDM2 (Ab1; Calbiochem, Darmstadt, Germany), anti-p21 WAF1/CIP1 (Ab1; Calbiochem) and anti-actin (MAB1501; Chemicon International, Temecula, CA, USA) antibodies.
p53 ubiquitination/neddylation assay Cells were transfected with 0.3 mg p53, 0.3 mg Ha-UB or HaNedd8, 0.05 mg MDM2, 0.5 mg p14 ARF , 0.25 mg L11 and 1.3 mg L5 as indicated using Effectene transfection reagent (Promega, Madison, WI, USA). A total of 10 mM (final) MG132 (Sigma) was added to the cells 20 h after transfection, and the cells were lysed and processed 6 h later as previously described (Lukashchuk and Vousden, 2007) . Immunoblots were probed with anti-HA (Y-11; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibody to detect modified p53, or anti-flag and anti-MDM2 (Ab1) for input immunoblot.
Immunoprecipitation experiments
Cell lysates were precleared with protein A sepharose. L5 was immunoprecipitated using anti-flag antibody, L11 was immunoprecipitated using anti-Myc antibody (9E10) or MDM2 was immunoprecipitated using SMP14 (Santa Cruz Biotechnology) at 4 1C overnight. Immunoprecipitates were washed in IP buffer, dissolved in sample buffer and resolved by 12% SDS-polyacrylamide gel electrophoresis. Previously described antibodies (Schatz et al., 1998; Lohrum et al., 2003) were used to detect endogenous L11 and L5. Ab2 (Calbiochem) was used to detect endogenous MDM2.
siRNA experiments For co-immunoprecipitation experiments, cells were transfected using calcium phosphate co-precipitation. Twenty-four hours later, cells were transfected with 200 or 400 pmol L11 siRNA (GGUGCGGGAGUAUGAGUUATT) or a scrambled control (GUGCGAGGGGGUUGUAAUCTT) as previously described (Bernardi et al., 2004) .
The p53 degradation assay was transfected as described. Twenty-four hours after the first transfection, cells were transfected with L11 siRNA or scrambled control. After 24 h, cells were washed in phosphate-buffered saline, lysed directly into sample buffer and resolved by 12% SDSpolyacrylamide gel electrophoresis.
5S rRNA binding
Ten-centimetre plates were transfected with 10 mg of flag-L11, flag-L11 R75Q or flag-L5 as indicated. After 48 h, cells were washed with phosphate-buffered saline, lysed in 400l IP lysis buffer and precleared with 40l protein A sepharose for 45 min. Anti-Flag antibody (2l, M2) and 30l protein A sepharose were added to each tube for 2 h. After washing twice with wash buffer (150 mM NaCl, 50 mM Tris (pH 8.0), 1% Triton X-100, 0.5% DOC, 0.1% SDS) and once with NET-2 buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 0.05 NP40), the immunoprecipitates were phenol/chloroform extracted. EtOH (2.5 vol, 100%), 0.3 M sodium acetate and 5 mg glycogen were added and stored at À80 1C overnight to precipitate the RNA. This was resuspended in 10l diethylpyrocarbonate-treated water. RNA (5l) was used for reverse transcriptase PCR analysis (SuperScript First Strand kit (Invitrogen, Paisley, UK)) using 5S rRNA-specific primers (5SFor(5 0 -GTCTACGGCCATACCACCCTG); 5SRev(5 0 -AAAGCCTAC AGCACCCGGTAT)).
